Role of nerve growth factor in plasticity of forebrain cholinergic neurons

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biochemistry (Moscow)

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S0006297917030075PMID 28320270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease

  2016cited by this paper
• Environmental enrichment aides in functional recovery following unilateral controlled cortical impact of the forelimb sensorimotor area however intranasal administration of nerve growth factor does not.

  2015cited by this paper
• NGF but not BDNF overexpression protects hippocampal LTP from beta-amyloid-induced impairment.

  2015cited by this paper
• Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.

  2015cited by this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cited by this paper
• NGF and therapeutic prospective: what have we learned from the NGF transgenic models?

  2015cited by this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cited by this paper
• Lentiviral-mediated overexpression of nerve growth factor (NGF) prevents beta-amyloid [25-35]-induced long term potentiation (LTP) decline in the rat hippocampus.

  2015cited by this paper
• Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro

  2015cited by this paper
• Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

  2015cited by this paper
• [Studying in vitro neuroprotective properties of GK-2(h)--a new original mimetic of human nerve growth factor].

  2014cited by this paper
• Intranasal nerve growth factor attenuates tau phosphorylation in brain after traumatic brain injury in rats.

  2014cited by this paper
• Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease

  2014cited by this paper
• Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome.

  2014cited by this paper
• Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor

  2014cited by this paper
• Novel small molecule activators of the Trk family of receptor tyrosine kinases.

  2013cited by this paper
• Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

  2013cited by this paper
• Brain aging and mitochondria-targeted plastoquinone antioxidants of SkQ-type

  2013cited by this paper
• Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer’s Disease

  2013cited by this paper
• Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity

  2012cited by this paper
• "Selective Growth Stimulating Effects of Mouse Sarcoma on the Sensory and Sympathetic Nervous System of the Chick Embryo" (1951), by Rita Levi-Montalcini and Viktor Hamburger

  2012cited by this paper
• Erratum: Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity (Cell Death and Disease (2012) 3 (e339) Doi: 10.1038/cddis.2012.80)

  2012cited by this paper
• [Neuroprotective effects of a dipeptide mimetic on the GK-2 nerve growth factor in model of permanent common carotid artery occlusion in rats].

  2012cited by this paper
• Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis

  2012cited by this paper
• In Vitro Study of Neuroprotective Properties of GK-2, a New Original Nerve Growth Factor Mimetic

  2011cited by this paper
• Ligand-Dependent TrkA Activity in Brain Differentially Affects Spatial Learning and Long-Term Memory

  2011cited by this paper
• Pathomorphology of the Heart Conduction System: Comparative Study during Increase in Left or Right Ventricular Afterload

  2011cited by this paper
• Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia

  2011cited by this paper
• Antiparkinsonian Properties of a Nerve Growth Factor Dipeptide Mimetic GK-2 in in Vivo Experiments

  2011cited by this paper
• Neuroprotective Effect of GK-2, a Dipeptide Mimetic of Nerve Growth Factor, during Experimental Focal Ischemia in Middle Cerebral Artery Basin

  2011cited by this paper
• Neural mechanisms of ageing and cognitive decline

  2010cited by this paper
• Development of a non invasive NGF-based therapy for Alzheimer's disease.

  2009cited by this paper
• NGF Is Essential for Hippocampal Plasticity and Learning

  2009cited by this paper
• NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children

  2009cited by this paper
• Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery.

  2009cited by this paper
• The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.

  2008cited by this paper
• A New Nerve Growth Factor-Mimetic Peptide Active on Neuropathic Pain in Rats

  2008cited by this paper
• Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease

  2008cited by this paper
• Alzheimer’s therapeutics

  2007cited by this paper
• Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice

  2006cited by this paper
• The effect of nerve growth factor on a selective increase in the cell body size of rat brain septal cholinergic neurons in a cell culture

  2006cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Long-Lasting Rescue of Age-Associated Deficits in Cognition and the CNS Cholinergic Phenotype by a Partial Agonist Peptidomimetic Ligand of TrkA

  2004cited by this paper
• - Amyloid Plaques in a Model for Sporadic Alzheimer ’ s Disease Based on Transgenic Anti-Nerve Growth Factor Antibodies

  2002cited by this paper
• Alzheimer's therapeutics: neurotrophin small molecule mimetics.

  2002cited by this paper
• Nerve growth factor: structure and function

  2001cited by this paper
• The Cytoplasmic and Transmembrane Domains of the p75 and Trk A Receptors Regulate High Affinity Binding to Nerve Growth Factor*

  2001cited by this paper
• A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors.

  2000cited by this paper
• Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits

  1997cited by this paper
• The cholinergic system in Alzheimer's disease.

  1997cited by this paper
• Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor‐dependent mechanism

  1997cited by this paper
• Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits

  1997cited by this paper
• Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer's type.

  1996cited by this paper
• p75 and Trk: a two-receptor system.

  1995cited by this paper
• [Effect of nerve growth on the selective increase in cell soma dimensions in septal cholinergic neurons of the rat brain under conditions of cultivation].

  1994cited by this paper
• Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia.

  1993cited by this paper
• Chapter 49: Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia

  1993cited by this paper
• Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma.

  1992cited by this paper
• Effect of nerve growth factor on cholinergic neurons in dissociated cultures of the septum pellucidum

  1991cited by this paper
• Aging is associated with a diffuse impairment of forebrain cholinergic neurons.

  1990cited by this paper
• [Role of nerve growth factor in CNS].

  1989influential reference
• Basal forebrain neurons undergo somatal and dendritic remodeling during postnatal development: a single-section Golgi and choline acetyltransferase analysis.

  1989influential reference
• The basal nucleus of Meynert revised: the nerve cell number decreases with age.

  1989cited by this paper
• Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro

  1988cited by this paper
• Morphological response of axotomized septal neurons to nerve growth factor

  1988cited by this paper
• Nerve Growth Factor Increases the Intracellular Content of Acetylcholine in Cultured Septal Neurons from Developing Rats

  1988cited by this paper
• Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment

  1988cited by this paper
• Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes

  1988cited by this paper
• Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage.

  1988cited by this paper
• The nerve growth factor: thirty‐five years later.

  1987cited by this paper
• Regional analysis of age-related changes in the cholinergic system of the hippocampal formation and basal forebrain of the rat.

  1987cited by this paper
• Nerve growth factor promotes development of the rat septo-hippocampal cholinergic projection in vitro.

  1987cited by this paper
• The nerve growth factor thirty-five years later

  1987cited by this paper
• The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration.

  1987cited by this paper
• Developmental changes of nerve growth factor and its mRNA in the rat hippocampus: comparison with choline acetyltransferase.

  1987cited by this paper
• Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain.

  1987cited by this paper
• Distribution of neuronal receptors for nerve growth factor in the rat

  1986cited by this paper
• Cholinergic denervation of the rat hippocampus by fimbrial transection leads to a transient accumulation of nerve growth factor (NGF) without change in mRNANGF content.

  1986influential reference
• Cholinergic but not monoaminergic denervation increases nerve growth factor content in the adult rat hippocampus and cerebral cortex

  1986cited by this paper
• Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.

  1985cited by this paper
• Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions.

  1984cited by this paper
• Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

  1984cited by this paper
• Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

  1983cited by this paper
• Human beta-nerve growth factor gene sequence highly homologous to that of mouse.

  1983cited by this paper
• Human β-nerve growth factor gene sequence highly homologous to that of mouse

  1983cited by this paper
• Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor

  1983cited by this paper
• NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?

  1983cited by this paper
• In vitro Evidence for two distinct hippocampal growth factors: basis of neuronal plasticity?

  1982cited by this paper
• EFFECTS OF THE EXTRACT OF THE MOUSE SUBMAXILLARY SALIVARY GLANDS ON THE SYMPATHETIC SYSTEM OF MAMMALS *

  1960cited by this paper
• In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo.

  1954cited by this paper
• Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo.

  1951cited by this paper

• Unveiling the Immune Landscape of Delirium through Single‐Cell RNA Sequencing and Machine Learning: Towards Precision Diagnosis and Therapy

  2025cites this paper
• Preservation of Septo-Hippocampal Theta Oscillations via Cholinergic Protection Underlies Cognitive Recovery After Physical Exercise Postcardiac Arrest.

  2025cites this paper
• Adolescent adversity persistently induces proinflammatory HMGB1 signaling and disrupts the basal forebrain cholinergic system in female rats

  2025cites this paper
• Dysmetabolism of the nerve growth factor pathway in the aging brain plays a pivotal role in cognitive decline.

  2025cites this paper
• Stimulation at the frontal cortex influences the exercise activity and skeletal muscle status in senescence-accelerating mice

  2025cites this paper
• Structural Engineering of Tyrosine-Based Neuroprotective Peptides: A New Strategy for Efficient Blood–Brain Barrier Penetration

  2025cites this paper
• Cholinotrophic basal forebrain connectome dysfunction in Down syndrome with and without dementia

  2025cites this paper
• Assessment of the functional return of an injured limb in a mouse model with Bcl-2 gene absent, following the application of locomotor training.

  2025cites this paper
• Impact of Neuroimmune System Activation by Adolescent Binge Alcohol Exposure on Adult Neurobiology.

  2025cites this paper
• Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)

  2023cites this paper
• Neurotrophic and Neuroprotective Effects of Hericium erinaceus

  2023cites this paper
• A New Dipeptide H-MGL Partially Ameliorating Memory Impairment in an STZ-induced Alzheimer Model in Male Rats

  2023cites this paper
• Melatonin Supports the Survival of Cholinergic Neurons in Organotypic Brain Slices of the Basal Nucleus of Meynert

  2023cites this paper
• A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable

  2022cites this paper
• Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood

  2022cites this paper
• Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression

  2022cites this paper
• Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration

  2022cites this paper
• The persistent impact of adolescent binge alcohol on adult brain structural, cellular, and behavioral pathology: A role for the neuroimmune system and epigenetics.

  2021cites this paper
• Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease

  2021cites this paper
• Impact of NGF signaling on neuroplasticity during depression: Insights in neuroplasticity-dependent therapeutic approaches

  2021cites this paper
• Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In vitro Model of Alzheimer's Disease.

  2021cites this paper
• Neuroprotective Effects of Physical Activity via the Adaptation of Astrocytes

  2021cites this paper
• Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease.

  2021cites this paper
• Anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer's disease: Nexus of cholinergic and nerve growth factor dysfunction.

  2021cites this paper
• Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction

  2020cites this paper
• Nerve Growth Factor in Alcohol Use Disorders

  2020cites this paper
• Centella asiatica L. Phytosome Improves Cognitive Performance by Promoting Bdnf Expression in Rat Prefrontal Cortex

  2020cites this paper
• NGF-Induced Nav1.7 Upregulation Contributes to Chronic Post-surgical Pain by Activating SGK1-Dependent Nedd4-2 Phosphorylation

  2020cites this paper
• GK-2 Reduces Death of Cultured Granule Neurons in Cerebellum Induced by the Toxic Effects of Zinc Ions

  2020cites this paper
• Neuroimmune and epigenetic involvement in adolescent binge ethanol‐induced loss of basal forebrain cholinergic neurons: Restoration with voluntary exercise

  2019cites this paper
• Synapse formation: from cellular and molecular mechanisms to neurodevelopmental and neurodegenerative disorders.

  2019cites this paper
• Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

  2019cites this paper
• Nerve growth factor metabolic dysfunction contributes to sevoflurane-induced cholinergic degeneration and cognitive impairments.

  2019cites this paper
• Enriched environment modulates behavior, myelination and augments molecules governing the plasticity in the forebrain region of rats exposed to chronic immobilization stress

  2019cites this paper
• Epigenetic Mechanisms in Neural Plasticity

  2019cites this paper
• THE IMPACT OF NEONATAL ALCOHOL EXPOSURE AND VOLUNTARY EXERCISE ON CHOLINERGIC FIBER LENGTH AND CG2 VOLUME IN THE RAT MEDIAL PREFRONTAL CORTEX

  2019cites this paper
• NGF protects neuroblastoma cells against β‐amyloid‐induced apoptosis via the Nrf2/HO‐1 pathway

  2019cites this paper
• AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients

  2018cites this paper
• The delayed protective effect of GK-2, а dipeptide mimetic of Nerve Growth Factor, in a model of rat traumatic brain injury.

  2018cites this paper
• Neurotrophins and cholinergic enzyme regulated by calpain-2: New insights into neuronal apoptosis induced by polybrominated diphenyl ether-153.

  2018cites this paper
• Rs7219 Regulates the Expression of GRB2 by Affecting miR-1288-Mediated Inhibition and Contributes to the Risk of Schizophrenia in the Chinese Han Population

  2018cites this paper
• Nerve Growth Factor Is Responsible for Exercise-Induced Recovery of Septohippocampal Cholinergic Structure and Function

  2018cites this paper
• Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin

  2018cites this paper
• The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain

  2018cites this paper
• Molecular mechanisms of neuroplasticity: An expanding universe

  2017cites this paper
• Cholinergic degeneration in early stages of Alzheimer’s disease: Loss of cholinergic phenotype or loss of cells?

  2017cites this paper